文献速递胃肠动力与功能性疾病

瑞典随机人群研究未发现肠易激综合征特异性微生物组特征

No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population.
PubMed 文献 · Gut · 2019-10-10

该研究基于瑞典PopCol随机人群队列,对376例乙状结肠活检和185例粪便样本行16S rRNA测序,其中IBS分别为63例和32例。结果显示IBS患者间微生物组异质性高于健康人,未观察到IBS特异性微生物特征;自评健康差或BMI高者肠道微生物丰富度较低。

要点

  • IBS患者与健康人之间未发现可区分的微生物组特征。
  • IBS患者个体间微生物组异质性高于健康个体。
  • 自评健康差或BMI高与肠道微生物丰富度降低相关。

核心结论

  • 在无结肠镜异常的社区人群中,IBS未表现出独特的微生物组特征。
  • IBS患者之间的微生物组异质性高于健康个体。
  • 自评健康差或BMI高与肠道微生物丰富度降低相关。

研究设计与样本

  • PopCol研究随机招募3556名成人,其中745人接受结肠镜检查。
  • IBS按Rome IV标准定义并排除器质性疾病。
  • 对376名代表性个体的乙状结肠活检样本(63例IBS)和185名个体的粪便样本(32例IBS)行16S rRNA基因测序。

主要发现

  • 乙状结肠黏膜相关微生物群以Lachnospiraceae为主,粪便中Ruminococcaceae相对丰度更高。
  • 同一人黏膜与粪便微生物丰富度线性相关(R²=0.255,p<3E-11),多样性相关(R²=0.06,p=0.0022)。
  • 黏膜微生物多样性随BMI升高(Pearson r=-0.1,p=0.08)和自评健康变差(r=-0.15,p=0.007)而降低。
  • 粪便微生物多样性与粪便稠度相关(r=-0.16,p=0.043)。
  • 多个分类群与年龄、BMI、抑郁和自评健康相关,如Coprococcus catus与较低抑郁水平相关(r=-0.003,p=0.00017)。

临床怎么用

  • 在社区人群中,不应仅凭微生物组特征诊断IBS。
  • 评估IBS患者时需考虑其微生物组的高异质性,避免过度解读单次检测结果。
  • 自评健康差或BMI高的个体可能肠道微生物丰富度较低,临床评估时可关注。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The ethiopathogenesis of irritable bowel syndrome (IBS) is unknown. While a link to the gut microbiome is postulated, the heterogeneity of the healthy gut makes it difficult to draw definitive conclusions. We aimed to describe the faecal and mucosa-associated microbiome (MAM) and health correlates on a community cohort of healthy and IBS individuals with no colonoscopic findings. DESIGN: The PopCol study recruited a random sample of 3556 adults; 745 underwent colonoscopy. IBS was defined by Rome IV criteria and organic disease excluded. 16S rRNA gene sequencing was conducted on sigmoid biopsy samples from 376 representative individuals (63 IBS cases) and faecal samples from 185 individuals (32 IBS cases). RESULTS: While sigmoid MAM was dominated by Lachnospiraceae, faeces presented a higher relative abundance of Ruminococcaceae. Microbial richness in MAM was linearly correlated to that in faeces from the same individual (R²=0.255, p<3E-11) as was diversity (R²=0.06, p=0.0022). MAM diversity decreased with increasing body mass index (BMI; Pearson's r=-0.1, p=0.08) and poorer self-rated health (r=-0.15, p=0.007), but no other health correlates. Faecal microbiome diversity was correlated to stool consistency (r=-0.16, p=0.043). Several taxonomic groups were correlated to age, BMI, depression and self-reported health, including Coprococcus catus associated with lower levels of depression (r=-0.003, p=0.00017). The degree of heterogeneity observed between IBS patients is higher than that observed between healthy individuals. CONCLUSIONS: No distinct microbial signature was observed in IBS. Individuals presenting with low self-rated health or high BMI have lower gut microbiome richness.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Hugerth LW, Andreasson A, Talley NJ, et al. No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population. Gut. 2019. PMID: 31601615. doi:10.1136/gutjnl-2019-318717

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。